Citation Impact
Citing Papers
A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies
2017
Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
2011
Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis
2007
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
2009
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
2005
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein
1993
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Triple-Negative Breast Cancer
2010 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
QuPath: Open source software for digital pathology image analysis
2017 Standout
Amplification of Tissue by Construction of Tissue Microarrays
2001
Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer
1993
Expression of luminal and basal cytokeratins in human breast carcinoma
2004
A view on drug resistance in cancer
2019 StandoutNature
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
2013
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
2016
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Histone methylation: a dynamic mark in health, disease and inheritance
2012 Standout
Recent Advances in the Care of the Patient with Malignant Melanoma
1997
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
1996 Standout
Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.
1998
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: A marker of hormone response
1987
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
2008
Leukocyte-endothelium adhesion: Microhemodynamics in mesentery of the cat
1987
Immunocytochemical Analysis of Estrogen Receptors in Human Breast Carcinomas
1990
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Chronic myelogenous leukemia: A review
1996
Cancer genes and the pathways they control
2004 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Pathological prognostic factors in breast cancer
1999 Standout
Tissue microarrays for high-throughput molecular profiling of tumor specimens
1998 Standout
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Localization of Progesterone Receptor with Monoclonal Antibodies to the Human Progestin Receptor*
1988
Histopathologic variables predict Oncotype DX™ Recurrence Score
2008
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Estrogen receptor immunohistoohemistry in carcinoma in situ of the breast
1992
Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: Prognostic significance
1996
Chronic Myelogenous Leukemia
2002
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
2000
Deficiency of Immunophilin FKBP52 Promotes Endometriosis
2008
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays
1990
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Quantitative imaging of immunocytochemical (pap) estrogen receptor staining patterns in breast cancer sections
1990
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
The role of senescent cells in ageing
2014 StandoutNature
Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment
1996
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples
1995
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
The PI3K Pathway in Human Disease
2017 Standout
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
2012 Standout
Loss of Dicer expression is associated with breast cancer progression and recurrence
2012
An assessment of the clinicohematological criteria for the accelerated phase of chronic myeloid leukemia
1996
The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy
1988
Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations
2005
Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia
1990
Breast cancer metastasis: markers and models
2005 Standout
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods
1997
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
2014
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
1990
Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival
1990
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
1990
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.
1989
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
2015
Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
2008
Interobserver Agreement Among Pathologists for Semiquantitative Hormone Receptor Scoring in Breast Carcinoma
2012
Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis.
2011
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Quality control in immunocytochemistry: experiences with the oestrogen receptor assay.
1992
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583 [see comments]
1993
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Diagnosing and Managing Advanced Chronic Myeloid Leukemia
2015
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia
1994
Graft‐versus‐Host Disease
1985
X-Tile
2004 Standout
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 StandoutScience
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
2008
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Chronic myeloid leukemia: current treatment options
2001
The Evaluation of Estrogen Receptor in Primary Breast Carcinoma by Computer-Assisted Image Analysis
1988
Nitric oxide: an endogenous modulator of leukocyte adhesion.
1991 Standout
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
1987
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of Cox Eb being referenced
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.
1985
Sex related survival differences in instances of melanoma.
1984
The response of human neutrophils to a chemotactic tripeptide (N-formyl- methionyl-leucyl-phenylalanine) studied by microcinematography
1984
Prognostic discrimination in "good-risk" chronic granulocytic leukemia
1984
Prognostic discrimination in "good-risk" chronic granulocytic leukemia
1984
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
1986